Initial Afferent Lymphatic Vessels Controlling Outbound Leukocyte Traffic from Skin to Lymph Nodes

Por Teijeira, Alvaro, Rouzaut, Ana, Melero, Ignacio
Publicado em 2013

T Cell Trafficking through Lymphatic Vessels

Por Hunter, Morgan C., Teijeira, Alvaro, Halin, Cornelia
Publicado no Front Immunol (2016)

New emerging targets in cancer immunotherapy: CD137/4-1BB costimulatory axis

Por Etxeberria, Iñaki, Glez-Vaz, Javier, Teijeira, Álvaro, Melero, Ignacio
Publicado no ESMO Open (2020)

ICAM-1-LFA-1 Dependent CD8+ T-Lymphocyte Aggregation in Tumor Tissue Prevents Recirculation to Draining Lymph Nodes

Por Yanguas, Alba, Garasa, Saray, Teijeira, Álvaro, Aubá, Cristina, Melero, Ignacio, Rouzaut, Ana
Publicado no Front Immunol (2018)

IL-1 Coordinates the Neutrophil Response to C. albicans in the Oral Mucosa

Por Altmeier, Simon, Toska, Albulena, Sparber, Florian, Teijeira, Alvaro, Halin, Cornelia, LeibundGut-Landmann, Salomé
Publicado no PLoS Pathog (2016)

Engineering bionic T cells: signal 1, signal 2, signal 3, reprogramming and the removal of inhibitory mechanisms

Por Etxeberria, Iñaki, Olivera, Irene, Bolaños, Elixabet, Cirella, Asunta, Teijeira, Álvaro, Berraondo, Pedro, Melero, Ignacio
Publicado no Cell Mol Immunol (2020)

Dendritic Cells and T Cells Interact Within Murine Afferent Lymphatic Capillaries

Por Hunter, Morgan Campbell, Teijeira, Alvaro, Montecchi, Riccardo, Russo, Erica, Runge, Peter, Kiefer, Friedemann, Halin, Cornelia
Publicado no Front Immunol (2019)

Cellular immunotherapies for cancer

Por Berraondo, Pedro, Labiano, Sara, Minute, Luna, Etxeberria, Iñaki, Vasquez, Marcos, Sanchez-Arraez, Alvaro, Teijeira, Alvaro, Melero, Ignacio
Publicado no Oncoimmunology (2017)

Repurposing infectious disease vaccines for intratumoral immunotherapy

Por Melero, Ignacio, Gato, Maria, Shekarian, Tala, Aznar, Angela, Valsesia-Wittmann, Sandrine, Caux, Christophe, Etxeberrria, Iñaki, Teijeira, Alvaro, Marabelle, Aurelien
Publicado no J Immunother Cancer (2020)

A Transgenic Prox1-Cre-tdTomato Reporter Mouse for Lymphatic Vessel Research

Por Bianchi, Roberta, Teijeira, Alvaro, Proulx, Steven T., Christiansen, Ailsa J., Seidel, Catharina D., Rülicke, Thomas, Mäkinen, Taija, Hägerling, René, Halin, Cornelia, Detmar, Michael
Publicado no PLoS One (2015)

Mouse Models of Peritoneal Carcinomatosis to Develop Clinical Applications

Por Bella, Ángela, Di Trani, Claudia Augusta, Fernández-Sendin, Myriam, Arrizabalaga, Leire, Cirella, Assunta, Teijeira, Álvaro, Medina-Echeverz, José, Melero, Ignacio, Berraondo, Pedro, Aranda, Fernando
Publicado no Cancers (Basel) (2021)

Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb

Por Bolaños-Mateo, Elixabet, Weigelin, Bettina, Teijeira, Alvaro, Martinez-Forero, Ivan, Labiano, Sara, Azpilicueta, Arantza, Morales-Kastresana, Aizea, Quetglas, Jose I, Wagena, Esther, Rodriguez, Alfonso, Chen, Lieping, Friedl, Peter, Melero, Ignacio
Publicado no J Immunother Cancer (2014)

Human CD8 T cells are susceptible to TNF-mediated activation-induced cell death

Por Otano, Itziar, Alvarez, Maite, Minute, Luna, Ochoa, María Carmen, Migueliz, Itziar, Molina, Carmen, Azpilikueta, Arantza, de Andrea, Carlos E., Etxeberria, Iñaki, Sanmamed, Miguel F., Teijeira, Álvaro, Berraondo, Pedro, Melero, Ignacio
Publicado no Theranostics (2020)

Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb

Por Weigelin, Bettina, Bolaños, Elixabet, Teijeira, Alvaro, Martinez-Forero, Ivan, Labiano, Sara, Azpilikueta, Arantza, Morales-Kastresana, Aizea, Quetglas, José I., Wagena, Esther, Sánchez-Paulete, Alfonso Rodríguez, Chen, Lieping, Friedl, Peter, Melero, Ignacio
Publicado no Proc Natl Acad Sci U S A (2015)

Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4–1BB)

Por Azpilikueta, Arantza, Bolaños, Elixabet, Lang, Valerie, Labiano, Sara, Aznar, Maria A., Etxeberria, Iñaki, Teijeira, Alvaro, Rodriguez-Ruiz, Maria E., Perez-Gracia, Jose L., Jure-Kunkel, Maria, Zapata, Juan M., Rodriguez, Manuel S., Melero, Ignacio
Publicado no Oncoimmunology (2017)

Repurposing the yellow fever vaccine for intratumoral immunotherapy

Por Aznar, Maria Angela, Molina, Carmen, Teijeira, Alvaro, Rodriguez, Inmaculada, Azpilikueta, Arantza, Garasa, Saray, Sanchez‐Paulete, Alfonso R, Cordeiro, Luna, Etxeberria, Iñaki, Alvarez, Maite, Rius‐Rocabert, Sergio, Nistal‐Villan, Estanislao, Berraondo, Pedro, Melero, Ignacio
Publicado no EMBO Mol Med (2019)

The clinical application of cancer immunotherapy based on naturally circulating dendritic cells

Por Bol, Kalijn F., Schreibelt, Gerty, Rabold, Katrin, Wculek, Stefanie K., Schwarze, Julia Katharina, Dzionek, Andrzej, Teijeira, Alvaro, Kandalaft, Lana E., Romero, Pedro, Coukos, George, Neyns, Bart, Sancho, David, Melero, Ignacio, de Vries, I. Jolanda M.
Publicado no J Immunother Cancer (2019)

Cellular cytotoxicity is a form of immunogenic cell death

Por Minute, Luna, Teijeira, Alvaro, Sanchez-Paulete, Alfonso R, Ochoa, Maria C, Alvarez, Maite, Otano, Itziar, Etxeberrria, Iñaki, Bolaños, Elixabet, Azpilikueta, Arantza, Garasa, Saray, Casares, Noelia, Luis Perez Gracia, Jose, Rodriguez-Ruiz, Maria E, Berraondo, Pedro, Melero, Ignacio
Publicado no J Immunother Cancer (2020)

Immunotherapeutic effects of intratumoral nanoplexed poly I:C

Por Aznar, M. Angela, Planelles, Lourdes, Perez-Olivares, Mercedes, Molina, Carmen, Garasa, Saray, Etxeberría, Iñaki, Perez, Guiomar, Rodriguez, Inmaculada, Bolaños, Elixabet, Lopez-Casas, Pedro, Rodriguez-Ruiz, Maria E., Perez-Gracia, Jose L., Marquez-Rodas, Ivan, Teijeira, Alvaro, Quintero, Marisol, Melero, Ignacio
Publicado no J Immunother Cancer (2019)

CD69 is a direct HIF-1α target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes

Por Labiano, Sara, Meléndez-Rodríguez, Florinda, Palazón, Asís, Teijeira, Álvaro, Garasa, Saray, Etxeberria, Iñaki, Aznar, M. Ángela, Sánchez-Paulete, Alfonso R., Azpilikueta, Arantza, Bolaños, Elixabet, Molina, Carmen, de la Fuente, Hortensia, Maiso, Patricia, Sánchez-Madrid, Francisco, de Landázuri, Manuel Ortiz, Aragonés, Julián, Melero, Ignacio
Publicado no Oncoimmunology (2017)